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Abstract
Background: Back pain is a leading contributor to disability, healthcare costs, and lost work. Family physicians are
the most common first point of contact in the healthcare system for people with back pain, but physiotherapists
(PTs) may be able to support the primary care team through evidence-based primary care. A cluster randomized
trial is needed to determine the clinical, health system, and societal impact of a primary care model that integrates
physiotherapists at the first visit for people with back pain. Prior to conducting a future fully powered cluster
randomized trial, we need to demonstrate feasibility of the methods. Therefore, the purpose of this pilot study will
be to:
1) Determine feasibility of patient recruitment, assessment procedures, and retention.
2) Determine the feasibility of training and implementation of a new PT-led primary care model for low back
pain (LBP)
3) Explore the perspectives of patients and healthcare providers (HCPs) related to their experiences and attitudes
towards the new service delivery model, barriers/facilitators to implementation, perceived satisfaction, perceived
value, and impact on clinic processes and patient outcomes.
Methods: This pilot cluster randomized controlled trial will enroll four sites and randomize them to implement a
new PT-led primary care model for back pain or a usual physician-led primary care model. All adults booking a
primary care visit for back pain will be invited to participate. Feasibility outcomes will include: recruitment and
retention rates, completeness of assessment data, PT training participation and confidence after training, and PT
treatment fidelity. Secondary outcomes will include the clinical, health system, cost, and process outcomes planned
for the future fully powered cluster trial. Results will be analyzed and reported descriptively and qualitatively. To
explore perspectives of both HCPs and patients, we will conduct semi-structured qualitative interviews with patients
and focus groups with HCPs from participants in the PT-led primary care sites.
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Discussion: If this pilot demonstrates feasibility, a fully powered trial will provide evidence that has the potential to
transform primary care for back pain. The full trial will inform future service design, whether these models should
be more widely implemented, and training agendas.
Trial registration: ClinicalTrials.gov, NCT03320148. Submitted for registration on 17 September 2017.
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Background
Back pain is the leading cause of years lived with disability
[1]; it costs the Canadian healthcare system between $6
and $12 billion annually [2], and is a leading contributor
to lost work productivity [3, 4]. The burden of back pain
on the Canadian healthcare system is further evidenced by
frequent healthcare utilization. The Canadian Institute for
Health Information (CIHI) suggests that low back pain
(LBP) was the sixth most common reason for emergency
department visits in 2010–2011, with over 150,000 visits
[5]. Back pain is also associated with a large number of
costly and unnecessary specialist consultations and diag-
nostic procedures [4, 6].
Back pain is the fifth most common reason for visiting
a primary care physician [7–9]. While physicians are the
most common first point of contact in the healthcare
system for people with back pain, questions remain
whether better patient outcomes could be achieved by
involving other healthcare providers (HCPs) within the
primary care team. For example, the use of physiothera-
pists (PTs) at the first visit might assist in the delivery of
evidence-based treatments, and greater use of pharma-
cists might help prevent current increases in opioid
prescription. Hartvigsen et al. [10, 11] argue for new pri-
mary care models to support physicians based on physi-
cians only receiving a few hours of musculoskeletal
training [12, 13] and low confidence in managing back
pain [14, 15]. Including PTs in the primary care team is
one way of helping address the workload challenge. If
more patients with back pain are given the choice of see-
ing a PT first, it is hypothesized that this could ease the
workload on physicians, provide a more focused back
pain consultation, and improve outcomes.
Several governments and health organizations have
identified team-based primary care as an important strat-
egy to improve the effectiveness and sustainability of
healthcare systems [16]. Advantages include improved ac-
cess to appropriate care, care coordination, and self-
management support. PTs may be an important team
member to integrate into primary care for people with
back pain. Evidence suggests that guideline-adherent care
for back pain improves function and disability [17, 18],
and that PTs can effectively implement recommendations
from primary care guidelines for back pain [19–22],
including: screening for red flags and the need for
diagnostic imaging [23–25]; screening for risk factors for
poor recovery [26–28]; providing reassurance, advice
about physical activity, and exercise recommendations
[29]; and delivering targeted, psychologically informed in-
terventions for those at greater risk of poor recovery [28].
This body of evidence suggests trained PTs could play a
greater role in providing guideline-adherent primary care
for people with back pain.
There is growing evidence to suggest that early referral
to PTs for back pain can reduce healthcare costs and
improve access to appropriate care. For example, a study
in the United States by Fritz et al. (n = 32,070) demon-
strated that early PT referral was associated with
reduced diagnostic imaging (odds ratio (OR) = 0.34),
physician visits (OR = 0.26), surgeries (OR = 0.45), and
use of opioid medications (OR = 0.78) over a 1-year
period [30]. The mean reduction per person in health-
care costs associated with early physiotherapy has been
reported to be from US$1202 to US$2736 [30, 31].
Furthermore, PTs in advanced practice roles have dem-
onstrated accurate assessment, appropriate screening,
and guideline-consistent triage [32], while reducing
spinal surgeon waiting times [33]. Research to date has
evaluated a model of care that includes a primary care
visit with the physician followed by early referral to a
PT. The proposed research will build on this evidence
by determining the feasibility of having PTs available to
patients as the first point of contact in the primary care
team for back pain.
There is emerging evidence from other settings that
suggests that PTs can adopt the primary care role
with good clinical outcomes and improvements in
healthcare efficiency. Studies in the United States
military have shown that when PTs provide the first
point of contact care for those with work-related in-
juries this produces high satisfaction ratings, faster
access, decreased sick calls, and more appropriate use
of PTs and physicians [24, 34–38]. Evidence on the
transition from physician referral to direct access
physiotherapy in the United Kingdom National Health
Service found higher levels of patient and physician
satisfaction, shorter physician wait times, fewer work
absences, fewer diagnostic images, and lower prescrip-
tion medication use [39–41]. These results are prom-
ising, but more rigorous evaluation methods and
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evidence specific to back pain and the Canadian pri-
mary care context are needed.
While PTs can provide effective care for back pain,
there are unique features of PTs practicing in primary
care that make it critical to rigorously evaluate new
models of care that incorporate PTs in primary care
teams. First, the majority of primary care visits are for
multiple health concerns [42]. It is important to evaluate
how new models of care impact the management of the
population most often seen in primary care, people with
multimorbidity and complex healthcare needs. Second,
PTs in Canada do not have independent prescribing
rights. Several centers in Canada have developed medical
directives that allow PTs to prescribe nonsteroidal anti-
inflammatory drugs under the authority of a physician
(e.g., for short-term pain relief in LBP [22, 43, 44]), but
these models need further evaluation. Third, it is unclear
whether patients or other HCPs are satisfied with this
model. One Canadian survey suggested high levels of
satisfaction and confidence in advanced practice PTs,
but this study was based on only 1% response to an elec-
tronic survey [45]. It is essential to better understand the
perspectives of patients and HCPs to inform a PT-led
primary care model for back pain.
The overarching aim of this line of research is to evaluate
a novel primary care model for back pain that incorporates
a PT at the first point of contact within the primary care
team for people with back pain. The planned fully powered
cluster randomized trial will have the following objectives:
1) Determine the effectiveness of a PT-led primary care
model for back pain on individual health outcomes
(function, pain intensity, quality of life, global rating of
change, and adverse events) in comparison to usual
physician led primary care.
2) Determine the impact of a PT-led primary care
model for back pain on the healthcare system and
society (healthcare accessibility, healthcare
utilization, and cost-effectiveness).
Prior to conducting the planned fully powered cluster
randomized trial, we need to test and demonstrate the
feasibility of the trial methods. To determine the feasibil-
ity of a fully powered cluster randomized trial, this
protocol is for a pilot cluster randomized trial with the
following objectives over a 1-year period:
1) Determine the feasibility of patient recruitment,
assessment procedures, and retention.
2) Determine the feasibility of training and implementation
of a new PT-led primary care model for back pain.
3) Explore the perspectives of patients and HCPs related
to their experiences and attitudes towards the new
service delivery model, barriers/facilitators to
implementation, perceived satisfaction, perceived value,
and impact on clinic processes and patient outcomes.
Methods
Design
This is a pilot cluster randomized controlled trial at four
primary care sites, with two sites randomized to a new
PT-led primary care model for back pain and two sites
randomized to usual physician-led primary care. A clus-
ter randomized trial was chosen because the interven-
tion includes integrating the PT into the clinical team
and clinic processes. This integration would make using
a traditional randomized controlled trial design difficult
and would introduce a high risk of contamination for
the usual care group. See Additional file 1 for completed
SPIRIT checklist. To explore perspectives of both HCPs
and patients, we will also conduct qualitative interviews
with patients and focus groups with HCPs who partici-
pated in the PT-led primary care intervention.
Enrollment and randomization of sites
For the pilot trial, four primary care practices in Kingston,
Ontario, Canada (Family Health Teams or Community
Health Centers) with a minimum of 2500 registered pa-
tients and two physicians each will be enrolled. We will
purposefully invite one community health center and
three family health teams to determine feasibility of the
protocol in both settings. Sites will be sorted in order of
size (number of registered patients) and placed into two
groups (the largest site and smallest site forming one
group and the middle two sites forming the other group).
The two groups will then be randomly allocated to inter-
vention or control arms by a statistician independent of
the enrollment of sites and collection of data using
computer-generated random numbers. The statistician
will be blinded to the site names using a concealed list of
anonymized codes for each site. We decided to randomize
using these two groups in order to balance the group sizes
for this pilot study given the large differences in number
of registered patients across anticipated sites (ranging
from 3000 to 16,000 patients). We anticipate using a
stratified block randomization based on the number of
registered patients for the full trial.
Blinding
HCPs and patients will not be blinded due to the nature
of the interventions being compared; that is, it is difficult
to blind patients or care providers to the models of care
being compared. All participants will be informed that
the trial is comparing a model of care that involves inte-
grating a physiotherapist within the primary care team
at the first point of contact with the team and a usual
care model that involves seeing their own family phys-
ician or nurse practitioner first. Since the primary
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outcome measures are self-report measures completed
by patients, the assessors will also not be blinded to their
allocation.
Patient enrollment
Medical secretaries will screen patients for willingness to
be invited to participate when they call to book an ap-
pointment. Patients who agree to being invited to par-
ticipate will be booked with an onsite research assistant
30 min before their appointment time. The research as-
sistant will provide information about the study, obtain
informed consent, and enroll consenting patients at the
time of their initial visit. Enrollment will take place over
a 14-week period starting in September 2017.
Inclusion/exclusion of patients
All adult (18 years and over) patients who ask to book a
primary care visit related to back pain of any duration at
any of the four participating primary care sites will be
invited to participate. The primary care visit may be a
first or repeat visit. Only patients who do not consent or
those who report not being able to understand, read,
and write English will be excluded.
Research ethics
This study has been approved by the Health Science and
Affiliated Teaching Hospitals Research Ethics Board
(HSREB #6021536). All participants provided informed
consent for participation. The study letter of information
and consent has been included in Additional file 2.
Interventions
Physiotherapist-led primary care model for back pain
The index intervention will be incorporating a PT within
the primary care team at the first point of contact for
people with back pain at no cost to the patient. Patients
in this model will be given the choice of seeing the PT
or family doctor. They will be encouraged to book with
the PT except when the primary reason for the visit is
for medication renewals or when the patient has add-
itional health concerns that need attention from their
physician in the same visit. There will be four key com-
ponents of the PT-led primary care intervention: 1)
initial assessment and screening; 2) brief individualized
intervention at the first visit; 3) health services naviga-
tion; 4) providing additional PT care for people with an
unmet need. For the pilot study, we will have one PT
providing care for both of the primary care practices in
the PT-led primary care model arm.
All participants who see the PT in primary care will be
able to book follow-up appointments. However, to avoid
duplication of available PT services, only those with an
identified need and no financial coverage for physiother-
apy services (i.e., no health insurance coverage for PT
and not meeting the criteria for PT funded by the minis-
try of health in Ontario) will be scheduled for a follow-
up appointment with the PT in primary care at the end
of the initial visit.
Assessment and screening
The assessment and screening will include: taking a
history; screening for red flags (e.g., signs/symptoms as-
sociated with cauda equina syndrome, traumatic frac-
ture, cancer, or widespread neurological symptoms);
physical and neurological examination; application of
evidence-based tools to identify comorbid health con-
ditions (e.g., depression) that require additional care
[46, 47]; and using a validated tool (STarT Back [27, 28])
to identify physical and psychosocial risk factors associ-
ated with ongoing pain and disability (Fig. 1).
Brief individualized intervention
The PTs will provide a brief individualized intervention at
the initial visit. This intervention will be based on primary
care guidelines for back pain [22] and will consist of
effective communication to validate the patient’s experi-
ences [48] and allow the patient to disclose the impact of
their back pain on their lives [49, 50], as well as providing
cognitive reassurance [51], a few exercises [52, 53], and
advice/strategies to stay active [54]. In line with evidence
for effective education, the recommendations will be sup-
ported with written information [55].
Health services navigation
The PT will assist the patient with back pain in navigat-
ing the appropriate healthcare services based on the as-
sessment findings (Fig. 1). First, they will identify any
red flags requiring emergency or urgent referrals. Next,
they will identify any comorbid conditions that need at-
tention from other members of the healthcare team; for
example, people who screen positive for depression will
be referred to their physician or a member of the mental
healthcare team. Finally, they will make a referral to PT
(if appropriate) informed by the patient’s score on the
STarT Back tool [27, 28]. The STarT Back tool effect-
ively categorizes patients with back pain into low,
medium, or high risk of ongoing pain and disability
based on physical and psychosocial risk factors for poor
recovery [27]. Low-risk patients will receive only the
brief individualized intervention at intake, medium-risk
patients will receive a referral for standard community
physiotherapy, and the high-risk patients will be referred
to a PT with specific training in combined physical and
psychologically informed practice aimed at reducing risk
factors for chronic pain and disability [56, 57]. The PT
in the primary care team will refer people classified as
medium or high risk to a community PT based on the fi-
nancial resources available to the patient (e.g., private
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PT referral when the patient has private health insurance
for PT or government-funded physiotherapy for those
who meet the specified criteria).
The STarT Back stratified approach to back pain man-
agement has been shown in a UK study to improve
function, quality of life, and cost-effectiveness in
Fig. 1 Overview of the PT in primary care screening and navigation process. The physiotherapist (PT) will help the patient navigate the healthcare system
in three stages. First, any red flags identified will lead to emergency, urgent, or soon referrals to the emergency department, physician, and/or imaging.
Second, the patient history, examination findings, and validated questionnaires, when appropriate, will be used to determine if other healthcare providers
are needed for this patient’s care. Third, the PT will use the STarT back risk stratification tool (individuals screened as low, medium, or high risk of ongoing
pain and disability [27]) to guide referral pathways for physiotherapy. The matched low-risk pathway is a brief primary care intervention (reassurance, advice,
and exercise) with no referral. The medium-risk pathway involves a referral for usual physiotherapy care in addition to the brief intervention. The high-risk
matched pathway includes referral for a combined physical and psychologically informed treatment approach which aims to address barriers to recovery,
facilitate increases in activity, and address unhelpful back pain beliefs and behaviors. This treatment approach has been described in more detail elsewhere
[56]. GAD-7 General Anxiety Disorder-7, NSAIDS nonsteroidal anti-inflammatory drugs, OT occupational therapy, PC primary care, PHQ-9 Patient Health
Questionnaire-9, PTSD post-traumatic stress disorder
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Fig. 2 Schedule of enrolment, interventions, and assessments
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comparison to usual care [28]. However, this stratified
approach has been difficult to implement in contexts
outside of the UK due to differences in funding models
for physiotherapy. For example, people classified as low
risk who have extended health insurance often use their
coverage for PT care, even though the STarT Back ap-
proach suggests these individuals are likely to experience
a full recovery without PT intervention. The PT-led pri-
mary care model for back pain utilized in this study will
aim to overcome this barrier using education and shared
decision making with patients classified as low risk. The
education will help patients understand that they are
likely to recover without additional PT services so that
they can make an informed decision about whether or
not to seek additional care using this knowledge. An-
other barrier to using the STarT Back stratified approach
to care in the Canadian context is that people classified
as medium or high risk often do not have financial
coverage for PT. The PT-led primary care model for
back pain utilized in this study will address this barrier
by providing ongoing PT care for people identified with
an unmet need.
Providing additional physiotherapy care to people with an
unmet need
The PT in primary care will provide additional physio-
therapy care (at the primary care site) to patients who
are classified as medium and high risk of ongoing pain
and disability (based on STarT Back screening) and who
do not have access to physiotherapy coverage through
either private or government health insurance plans.
The care will include evidence-based strategies, such as
individualized education [58], exercise [52, 53], and
cognitive behavioral approaches [56].
Physiotherapist training
The registered physiotherapist involved in the new PT-
led primary care model for back pain will participate in
5 days of training including:
i. a review of red-flag screening;
ii. screening for comorbidities and services available
within the participating family health teams and
community health center for people with these
conditions;
iii. examination of back pain including subjective and
physical assessment according to clinical practice
guidelines;
iv. using and interpreting outcome measures and
screening tools for people with back pain;
v. diagnostic imaging guidelines for back pain and how
to appropriately utilize imaging findings from a
radiologist in clinical decision making;
vi. using the STarT Back tool to classify people with
back pain into low, medium, or high risk of ongoing
pain and disability, and how to refer to a PT based
on the classification;
vii. PT services available in the Kingston, Ontario, area
based on patient healthcare resources (e.g., private
clinics, Ontario Health Insurance Plan-funded
physiotherapy clinics)
viii.the brief primary care intervention for people with
back pain, including cognitive reassurance, education
regarding prognosis and the importance of
continued participation in usual life-role activities,
and brief prescription of physical activity and
exercise;
ix. activity-based PT for people identified at medium
risk of ongoing pain and disability based on STarT
Back screening. This will include education, graded
activity, and exercise.
x. additional interventions aimed at reducing
psychosocial risk factors for people classified at high
risk of ongoing pain and disability by the STarT back
screening. This will include communication skills to
facilitate personal disclosure, pain neurophysiology
education, de-catastrophizing interventions, graded
exposure to reduce activity-related fear, pacing
strategies, cognitive-behavioral strategies to improve
self-efficacy and facilitate behavior change, as well as
strategies to improve sleep, manage stress, and
manage flare-ups
Usual physician-led care model
The physician-led primary care intervention will be un-
standardized to best reflect standard clinical practice in
Canada. This usually includes a visit to a primary care
physician, who would perform a history and physical
examination, provide back pain education, and prescribe
medications and/or refer based on their assessment find-
ings and patient preferences. Participants in both groups
will be permitted to seek additional care which will be
monitored through a healthcare utilization questionnaire
administered at all follow-up assessments.
Evaluation and outcomes
The feasibility outcomes described below will be the pri-
mary outcomes of this pilot study. These measures will
be used to inform a full-scale trial including how many
sites to involve, which measures to include, and how to
effectively train the PTs. Secondary outcomes will in-
clude the clinical, health system, and process outcomes
planned for the full trial. We will determine the feasibil-
ity for collecting these outcomes and report them de-
scriptively, but no comparisons will be made between
groups. Data collection forms are available from the au-
thors upon request.
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Feasibility outcomes
Recruitment of primary care teams Recruitment and
retention of four family health teams or community
health centers will be an essential feasibility criterion for
proceeding with the full trial.
Recruitment of patients The feasibility of patient re-
cruitment will be determined by the overall recruitment
rate. The full trial will be considered feasible if, during
the pilot study, we are able to recruit 21 patients over 13
weeks using four sites. This recruitment rate will allow
us to exceed our preliminary sample size calculated for
the full trial (n = 640) with 16 sites over 2.5 years. This
sample size will be recalculated based on the pilot data,
and the recruitment rate from this pilot study will in-
form whether our preliminary plan of using 16 sites over
2.5 years is feasible or if additional sites or a longer re-
cruitment period are needed.
Assessment procedures Feasibility of the assessment
procedures will be measured by completeness of data
and duration of completing all outcome measures
among all people that start each assessment. As recom-
mended for pilot studies, we set criteria a priori for ac-
ceptable completeness [59], and will consider > 80% of
all assessment items completed and a mean time for
completion of < 60 min as acceptable.
Retention Retention will be assessed by attrition rate,
with < 20% attrition at 12-month follow-up considered in-
dicative of a fully successful pilot with a plan of using the
retention strategies from the pilot in the full trial, < 35%
attrition will be considered partially successful with a plan
to proceed with the full trial, but with additional retention
strategies identified and implemented for the full trial
based on evidence that > 20% attrition threatens trial
validity [60].
Physiotherapist training Feasibility of training the PT
who will adopt the primary care role will be evaluated
through attendance, ratings of self-efficacy (0–10) for
delivering each of the four components of the interven-
tion after training, and qualitative feedback. A successful
outcome will be considered as full attendance in the
training and self-efficacy ratings of at least 8/10 on each
component of the intervention. Qualitative feedback will
be used to inform the PT training in the full trial.
Physiotherapist treatment fidelity Treatment fidelity
will be encouraged through training and by providing a
treatment fidelity checklist to the participating PTs.
Fidelity will be measured through an audit of the fidelity
checklist and electronic medical record (EMR) of each
included patient to determine consistency of the
intervention with the protocol [61]. An acceptable level
of fidelity will be considered > 80% for red-flag screen-
ing, reassurance, advice to stay active, exercises, and re-
ferral consistent with the intervention decision tree.
Baseline factors used to describe the population
In order to describe the population at baseline, we will
collect the following baseline information from partici-
pants: age, gender, duration of back pain, whether there
have been previous episodes of back pain, whether or
not the participant has pain in other areas of the body,
medications, comorbidities, work status prior to onset of
back pain, and current work status.
Clinical outcomes
In preparation for the future fully powered trial, we will
pilot the data collection for the clinical outcomes via this
pilot study. All measures will be collected through either
electronic or paper data collection forms with the assist-
ance of a trained research assistant at baseline, 6 weeks,
and 3, 6, 9, and 12 months, with the primary time point
for comparison being the 12-month follow-up (Fig. 2).
The following clinical effectiveness outcomes will be
piloted in this study.
Self-reported disability will be made using the Roland
Morris Questionnaire (RMQ), which demonstrates reli-
ability, validity, and responsiveness in people with acute
and chronic back pain [62, 63].
Pain intensity will be measured using a Numeric Pain
Rating Scale (NPRS) at sitting, which has shown good
reliability and responsiveness in acute and chronic back
pain [64]. We will ask patients to report their pain at
rest and during two physical activities (walking and lift-
ing a grocery bag) based on evidence that exercise-
evoked pain may respond differently to treatment than
pain at rest [65–67].
Health-related quality of life will be reported using the
EuroQOL-5D (EQ-5D) [68], a preference-based measure
that performs well in LBP and is suitable for economic
evaluation in this population [69]. The EQ-5D score will
also be converted to quality-adjusted life years (QALY)
using the UK VAS A3 value set as recommended in the
absence of Canadian value sets [68].
Global rating of change will be assessed using an
11-point global rating of change scale (GROC) (–5 to +5)
as has been recommended in the literature for self-
reported rating of change [70, 71].
Patient satisfaction will be assessed using an 11-point
scale with anchors of very dissatisfied (–5) and very sat-
isfied (+5).
Catastrophic thinking will be assessed using the 13-item
Pain Catastrophizing Scale (PCS) [72].
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Depressive symptoms will be assessed using the nine-
item Patient Health Questionnaire (PHQ-9) [73].
Adverse events will be reported using an adverse
events questionnaire that is reported to be consistent
with reporting guidelines [74, 75], and asks: 1) if the
patient has experienced any events as a result of any of
the treatments received (yes/no); 2) how long the event
lasted (hours or days); 3) how severe the adverse event
was (0–10 scale); and 4) what adverse events were expe-
rienced. Any serious adverse events will be addressed
immediately by referral to the most appropriate member
of the primary healthcare team.
Health system outcomes
We will pilot data collection needed to analyze the fol-
lowing health system outcomes:
Accessibility will be measured using the percentage of
patients with back pain who are assessed by a primary
care provider within 48 h and the percentage of patients
who score medium or high risk on the STarT Back
screening tool who access physiotherapy (as endorsed by
guidelines [76]).
Healthcare utilization will be assessed using a self-
report questionnaire at each assessment focused on the
following health services: primary care visits (physicians,
nurse practitioners, PT in primary care), emergency
room visits, hospitalizations, surgeries, consultations
with other healthcare professionals (e.g., other PTs, chi-
ropractors, physician specialists, clinics), diagnostic im-
aging (e.g., x-ray, computed tomography (CT), magnetic
resonance imaging (MRI)), medications, and other costs
borne by the participant (e.g., other treatment).
Cost outcomes
We will pilot data collection to be able to perform a cost
utility analysis in the full trial.
Sources of direct healthcare cost data Intervention
costs will include the PT salary, training, materials, and
space needed to carry out the intervention. Costs for
publically funded healthcare services will be calculated
using the Ontario Ministry of Health and Long-term
Care Schedule of Benefits [77]. Medication costs will be
obtained from the Ontario Drug Benefit formulary. For
private healthcare services, the mean cost for the ser-
vices in the community served will be used (e.g., we sur-
veyed PTs in Kingston and found mean costs of $80 for
initial and $60 for follow-up visits).
Indirect costs Non-healthcare costs will be limited to
loss of productivity (LOP) using a human capital ap-
proach. The mean Canadian wage reported by Statistics
Canada will be used to assign a monetary value to time
lost from paid employment by both patients and
caregivers collected via self-report measures at each
follow-up assessment. The minimum wage value in On-
tario will be used to place a value on time lost by those
who were retired as well as on time away from volunteer
or homemaking activities.
Process outcomes
We will pilot the collection of process outcomes to de-
termine the feasibility of comparing differences in man-
agement between groups in the full trial. The following
process outcomes will be collected from the electronic
medical record: medications prescribed, diagnostic im-
aging ordered, referrals made to other HCPs (both in-
ternal and external to the primary healthcare team), the
number of visits to members of the primary care team,
and notes to employers or insurers provided. Number of
visits to HCPs outside of the primary care team will be
recorded via patient diary.
Data collection and management
All data will be collected on electronic or paper data col-
lection forms (depending on participant preference).
Participants will be instructed on how to complete the
questionnaires by trained research assistants and data
will be entered into an encrypted and secure study data-
base. Personal identifying information including name,
date of birth, and contact information will be collected
for obtaining data from the electronic medical record
and for contacting participants for follow-up appoint-
ments. This personal information will be stored in a sep-
arate file from participant data that is also encrypted and
password protect. The file that contains personal identi-
fiers will be destroyed at the end of the trial and de-
identified data will be permanently anonymized. Only
study investigators and research staff will have access to
the data. Data quality will be assured by checking 10% of
data from the database with original data collection
forms. Research assistants will schedule follow-up visits
with participants at the initial visit and will call or email
(based on participant preference) 1 week in advance to
remind the participant of their approaching assessment.
Multiple attempts will be made to contact participants
by phone or email for any participants who miss an ap-
pointment without cancellation.
Analysis
In keeping with methodological recommendations and
reporting guidelines for pilot and feasibility studies
[59, 78, 79], all feasibility outcomes will be reported
descriptively and analyzed qualitatively. Descriptive statis-
tics for each of the clinical, health system, and process
outcomes will be reported in aggregate only to avoid
potentially influencing a decision about proceeding with
the full trial based on preliminary data. We will use means
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(standard deviation) for continuous variables that are nor-
mally distributed or medians (interquartile range) for
continuous variables that are not normally distributed.
Categorical variables will be presented as count and per-
centage for each category. The total costs will be deter-
mined by multiplying the quantity of resource use by the
corresponding unit cost, summing the total cost over each
follow-up interval, and then calculating the mean cost at
each follow-up time point, as well as an overall mean cost
for the entire study period. Results will be presented as ag-
gregated and disaggregated costs. We will document
challenges in collection of economic data to inform the
plan for the full trial, where we intend to perform a
complete cost-utility analysis. We will perform an in-
terim analysis after the recruitment period, 6-week, and
3-month follow-ups are completed for all participants
in order to plan for the full trial. The remaining follow-
ups (6, 9, and 12 months) will be analyzed after the final
participant has completed the 12-month follow-up.
Sample size
The preliminary sample size calculated for the planned
fully powered cluster randomized trial is 16 practices
with an average of 40 patients per practice (640 patients
in total). This will achieve 90% power to detect a minim-
ally important mean difference of 2.5 points on the
RMQ [80] at 3-month follow-up (Cohen’s d = 0.4) using
a two-sided α = 0.05 and assuming a standard deviation
of 6.2 points [28], an intracluster correlation coefficient
of 0.01 [81], an expected variation in recruitment per
practice using a coefficient of variation of 0.65 [82], and
accounting for 20% attrition. This calculation is prelim-
inary and we will re-visit this sample size calculation
based on the data obtained from this pilot study. For this
pilot study, we plan to recruit patients from four pri-
mary care teams over a period of 14 weeks. The pilot
sample size is based on logistical considerations rather
than formal power considerations. The four primary care
sites that will be invited to participate have approxi-
mately 24 full-time equivalent (FTE) physicians in total,
averaging 26 clinical hours/week, a minimum of two pa-
tients/clinical hour, and an anticipated 1.5% of visits for
back pain. Based on 25% enrolment in our previous
work [28], we anticipate 65 patients over the 14-week re-
cruitment period, far exceeding our feasibility target of
21 patients over 13 weeks.
Associated qualitative interviews and focus groups
To explore the perspectives of patients, we will interview
approximately 10 to 15 patients who received care at the
sites that incorporated a PT in the primary care team.
We will use purposive sampling to identify participants
who have been classified as low, medium, and high risk
based on the STarT Back classification. Furthermore, we
will sample from participants who are appropriate for
additional PT care who have received a referral and
those that have received ongoing care from the PT in
the primary care setting. We will continue with inter-
views until saturation. We will use semi-structured inter-
view guides that explore experiences and attitudes
towards the new service delivery model, barriers/facilita-
tors to implementation, perceived satisfaction, perceived
value, and impact on clinic processes and patient out-
come. The data will be recorded, transcribed verbatim,
and coded in an interpretive description tradition [83, 84]
to develop clinically meaningful themes. Two investigators
will independently review interview transcripts and iden-
tify themes using interpretive description [83, 84]. The
findings from these qualitative interviews will provide rich
data upon which to inform any necessary changes for the
full trial, including changes to the PT training, imple-
mentation of the intervention and assessment proce-
dures, and communication between the researchers and
healthcare team.
To explore the perspective of HCPs, we will conduct
two focus groups with each of the primary care teams
who integrate a PT within their team. Similar to the in-
terviews with patients, the focus groups will ask HCPs
about their experiences and attitudes towards the new
service delivery model, barriers/facilitators to implemen-
tation, perceived satisfaction, perceived value, and im-
pact on clinic processes and patient outcomes.
Protocol amendments
Protocol amendments will be will be communicated by
updating the trial registry at ClinicalTrials.gov, contact-
ing all investigators and participants, and reporting in
the final trial publication.
Knowledge translation and dissemination
This pilot study will serve as an important opportunity
to engage target stakeholders (patients, HCPs, adminis-
trators, policy makers) who will support effective know-
ledge translation (KT) activities throughout the full trial.
During the pilot study we will solicit feedback on the
protocol from members of each of these target stake-
holder groups to inform the conduct of the fully pow-
ered trial and will work with these stakeholders to
develop a clearly articulated KT plan for the full trial.
Our team knowledge users (LC and CM) will work with
investigators to develop the KT plan. Findings from this
pilot study will be presented at local rounds at partici-
pating sites, provincial and national scientific confer-
ences, and published in journals in the fields of primary
care or rehabilitation. Authorship will be determined
using the International Committee of Medical Journal
Editors (ICMJE) recommended authorship criteria.
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Discussion
This study will determine the feasibility of a cluster ran-
domized controlled trial investigating the impact of a
new PT-led primary care model for back pain. If this
pilot demonstrates feasibility, a fully powered trial will
provide evidence that has the potential to transform pri-
mary care for back pain in Canada. The full trial will in-
form future service design and whether these models
should be more widely implemented. It will also inform
workforce development and training agendas. Expansion
of the primary care team is being advocated as one way
of meeting increasing demand and, although this study
focuses on back pain and PTs, the findings will have
relevance to other clinical conditions and healthcare
professionals.
Additional files
Additional file 1: Informed consent form for study participants. (DOCX 55 kb)
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